Skip to main content

Advertisement

Log in

Comparative Analysis of Quantitative Parameters of Expression of the Retinoic Acid Nuclear Receptor RARα Gene and APE1/YB-1/MDR1 Pattern Genes in Patients with Newly Detected Multiple Myeloma

  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

The expression of retinoic acid nuclear receptor gene RARα and its relationship with expression of APE1, YB-1, and MDR1 genes was studied in bone marrow aspiration biopsy specimens from 22 patients with newly detected multiple myeloma. The expression of RARα directly correlated with the expression of APE1/YB-1/MDR1 pattern genes. Groups differing by expression of RARα exhibited significant differences in the overall survival of patients; concordant and simultaneous changes in the expression of all genes of the APE1/YB-1/MDR1 pattern suggested the level of RARα gene expression as a potential prognostic factor in the pathogenesis of multiple myeloma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Kalitin NN, Buravtsova IV. Correlation between Expression of RARα Transcription Factor and Genes of VEGFR3-Dependent Signaling System in Multiple Myeloma. Klin. Onkogematol. 2015;8(1):31-35. Russian.

    Google Scholar 

  2. Bjorklund CC, Baladandayuthapani V, Lin HY, Jones RJ, Kuiatse I, Wang H, Yang J, Shah JJ, Thomas SK, Wang M, Weber DM, Orlowski RZ. Evidence of a role for CD44 and cell adhe-sion in mediating resistance to lenalidomide in multiple myeloma: therapeutic implications. Leukemia. 2014;28(2):373-383.

    Article  CAS  PubMed  Google Scholar 

  3. Boyle EM, Davies FE, Leleu X, Morgan GJ. Understanding the multiple biological aspects leading to myeloma. Haematologica. 2014;99(4):605-612.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Chambon P. A decade of molecular biology of retinoic acid receptors. FASEB J. 1996;10(9):940-954.

    CAS  PubMed  Google Scholar 

  5. Chatterjee M, Rancso C, Stühmer T, Eckstein N, Andrulis M, Gerecke C, Lorentz H, Royer HD, Bargou RC. The Y-box binding protein YB-1 is associated with progressive disease and mediates survival and drug resistance in multiple myeloma. Blood. 2008;111(7):3714-3722.

    Article  CAS  PubMed  Google Scholar 

  6. Chattopadhyay R, Das S, Maiti AK, Boldogh I, Xie J, Hazra TK, Kohno K, Mitra S, Bhakat KK. Regulatory role of human AP-endonuclease (APE1/Ref-1) in YB-1-mediated activation of the multidrug resistance gene MDR1. Mol. Cell. Biol. 2008;28(23):7066-7080.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. di Masi A, Leboffe L, De Marinis E, Pagano F, Cicconi L, Rochette-Egly C, Lo-Coco F, Ascenzi P, Nervi C. Retinoic acid receptors: from molecular mechanisms to cancer therapy. Mol. spects Med. 2015;41:1-115.

  8. Durie BG, Salmon SE. A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. Cancer. 1975;36(3):842-854.

    Article  CAS  PubMed  Google Scholar 

  9. Koskela K, Pelliniemi TT, Pulkki K, Remes K. Treatment of multiple myeloma with all-trans retinoic acid alone and in combination with chemotherapy: a phase I/II trial. Leuk. Lymphoma. 2004;45(4):749-754.

    Article  CAS  PubMed  Google Scholar 

  10. Levy Y, Labaume S, Colombel M, Brouet JC. Retinoic acid modulates the in vivo and in vitro growth of IL-6 autocrine human myeloma cell lines via induction of apoptosis. Clin. Exp. Immunol. 1996;104(1):167-172.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Liu Z, Li T, Jiang K, Huang Q, Chen Y, Qian F. Induction of chemoresistance by all-trans retinoic acid via a noncanonical signaling in multiple myeloma cells. PLoS One. 2014;9(1):e85571. doi:https://doi.org/10.1371/journal.pone.0085571.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Maeno T, Tanaka T, Sando Y, Suga T, Maeno Y, Nakagawa J, Hosono T, Sato M, Akiyama H, Kishi S, Nagai R, Kurabayashi M. Stimulation of vascular endothelial growth factor gene transcription by all trans retinoic acid through Sp1 and Sp3 sites in human bronchioloalveolar carcinoma cells. Am. J. Respir. Cell Mol. Biol. 2002;26(2):246-253.

    Article  CAS  PubMed  Google Scholar 

  13. Rajkumar SV. Treatment of multiple myeloma. Nat. Rev. Clin. Oncol. 2011;8(8):479-491.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Sengupta S, Mantha AK, Mitra S, Bhakat KK. Human AP endonuclease (APE1/Ref-1) and its acetylation regulate YB-1-p300 recruitment and RNA polymerase II loading in the drug-induced activation of multidrug resistance gene MDR1. Oncogene. 2011;30(4):482-493.

    Article  CAS  PubMed  Google Scholar 

  15. Tsuzuki S, Kitajima K, Nakano T, Glasow A, Zelent A, Enver T. Cross talk between retinoic acid signaling and transcription factor GATA-2. Mol. Cell. Biol. 2002;24(15):6824-6836.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to N. N. Kalitin.

Additional information

Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 163, No. 7, pp. 105-109, July, 2017

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kalitin, N.N., Chernykh, Y.B. & Buravtsova, I.V. Comparative Analysis of Quantitative Parameters of Expression of the Retinoic Acid Nuclear Receptor RARα Gene and APE1/YB-1/MDR1 Pattern Genes in Patients with Newly Detected Multiple Myeloma. Bull Exp Biol Med 164, 90–94 (2017). https://doi.org/10.1007/s10517-017-3931-7

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10517-017-3931-7

Key Words

Navigation